Eleonora Pozzi
Overview
Explore the profile of Eleonora Pozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zippo A, Rodriguez-Menendez V, Pozzi E, Canta A, Chiorazzi A, Ballarini E, et al.
J Peripher Nerv Syst
. 2024 Oct;
29(4):537-554.
PMID: 39434652
Background And Aims: Chemotherapy-induced peripheral neurotoxicity (CIPN), with paraesthesia, numbness, dysesthesia and neuropathic pain ranks among the most common dose-limiting toxicity of several widely used anticancer drugs. Recent studies revealed...
2.
Utkina-Sosunova I, Chiorazzi A, de Planell-Saguer M, Li H, Meregalli C, Pozzi E, et al.
Sci Rep
. 2024 Aug;
14(1):19341.
PMID: 39164364
Peripheral neurotoxicity is a dose-limiting adverse reaction of primary frontline chemotherapeutic agents, including vincristine. Neuropathy can be so disabling that patients drop out of potentially curative therapy, negatively impacting cancer...
3.
DAcapito F, Framarini M, Pietrantonio D, Tauceri F, Zucchini V, Pozzi E, et al.
Medicina (Kaunas)
. 2024 Jul;
60(7).
PMID: 39064487
Multimodal treatment in peritoneal metastases (PM) from colorectal neoplasms may improve overall survival (OS). In this study, we reported our experience in using cytoreductive surgery (CRS) combined with intraperitoneal chemohyperthermia...
4.
Pozzi E, Terribile G, Cherchi L, Di Girolamo S, Sancini G, Alberti P
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928257
The peripheral nervous system can encounter alterations due to exposure to some of the most commonly used anticancer drugs (platinum drugs, taxanes, vinca alkaloids, proteasome inhibitors, thalidomide), the so-called chemotherapy-induced...
5.
Sullo F, Passardi A, Gallio C, Molinari C, Marisi G, Pozzi E, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731090
Rectal cancer presents a significant burden globally, often requiring multimodal therapy for locally advanced cases. Long-course chemoradiotherapy (LCRT) and short-course radiotherapy (SCRT) followed by surgery have been conventional neoadjuvant approaches....
6.
Cavaletti G, Alberti P, Canta A, Carozzi V, Cherchi L, Chiorazzi A, et al.
Pain
. 2024 May;
165(11):2482-2493.
PMID: 38723182
Paclitaxel-induced peripheral neurotoxicity (PIPN) is a potentially dose-limiting side effect in anticancer chemotherapy. Several animal models of PIPN exist, but their results are sometimes difficult to be translated into the...
7.
Bonomo R, Canta A, Chiorazzi A, Carozzi V, Meregalli C, Pozzi E, et al.
J Peripher Nerv Syst
. 2023 Dec;
29(1):58-71.
PMID: 38126610
Background And Aims: Chemotherapy-induced peripheral neurotoxicity (CIPN) is one of the most common dose-limiting side effects of paclitaxel (PTX) treatment. Many age-related changes have been hypothesized to underlie susceptibility to...
8.
Chiorazzi A, Canta A, Carozzi V, Meregalli C, Pozzi E, Ballarini E, et al.
J Peripher Nerv Syst
. 2023 Nov;
29(1):47-57.
PMID: 38009865
Background And Aims: Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common and long-lasting adverse event of several anticancer compounds, for which treatment has not yet been developed. To fill this gap,...
9.
Dionisi M, Riva B, Delconti M, Meregalli C, Chiorazzi A, Canta A, et al.
Sci Rep
. 2023 Mar;
13(1):3991.
PMID: 36894669
Oxaliplatin (OHP)-induced peripheral neurotoxicity (OIPN), one of the major dose-limiting side effects of colorectal cancer treatment, is characterized by both acute and chronic syndromes. Acute exposure to low dose OHP...
10.
Pozzi E, Ballarini E, Rodriguez-Menendez V, Canta A, Chiorazzi A, Monza L, et al.
Toxics
. 2023 Feb;
11(2).
PMID: 36850969
Chemotherapy-induced peripheral neurotoxicity is one of the most common dose-limiting toxicities of several widely used anticancer drugs such as platinum derivatives (cisplatin) and taxanes (paclitaxel). Several molecular mechanisms related to...